• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers

    EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer

    This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...

    Impressions : 3983

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.